All In MedTech

FDA Clearance Tracker · P020006-S008

ENTERYX PROCEDURE KIT

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jun 2, 2005 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Jun 2, 2005

Approved

Time to decision

143 days

Received Jan 10, 2005. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P020006-S008
Device name
ENTERYX PROCEDURE KIT
Applicant location
Marlborough, MA
Received
Jan 10, 2005
Decided
Jun 2, 2005
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P020006

Device type

Device class
Class III

Every decision under product code LNM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT BOSTON SCIENTIFIC CORPORATION, WAYNE, NEW JERSEY TO CONDUCT PACKAGING AND LABELING OPERATIONS.

Source documents

Other decisions for Boston Scientific Corp

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.